Utilization patterns and cost of complementary and alternative medicine compared to conventional medicine in patients with type 2 diabetes mellitus.

Kim, Hae Jin; Chun, Ki Hong; Kim, Dae Jung; Han, Seung Jin; Kim, Young Seol; Woo, Jeong Taek; Park, Yongsoo; Nam, Moon Suk; Baik, Sei Hyun; Ahn, Kyu Jeung; Lee, Kwan Woo
Diabetes research and clinical practice
2011Jul ; 93 ( 1 ) :115-22.
ÀúÀÚ »ó¼¼Á¤º¸
Kim, Hae Jin -
Chun, Ki Hong -
Kim, Dae Jung -
Han, Seung Jin -
Kim, Young Seol -
Woo, Jeong Taek -
Park, Yongsoo -
Nam, Moon Suk -
Baik, Sei Hyun -
Ahn, Kyu Jeung -
Lee, Kwan Woo -
ABSTRACT
AIMS: We evaluated the use and annual cost of complementary and alternative medicine (CAM) compared to conventional medicine in type 2 diabetes mellitus (DM) in the Korean population.

METHODS: We analyzed the database of 2752 DM patients obtained from the Korean National Diabetes Program (KNDP). The cost data of conventional medicine starting 1-year before enrolment of the KNDP were obtained from the hospital electronic database. The cost data of CAM over the same period were obtained from questionnaires.

RESULTS: Among the 2752 subjects, 677 patients (24.6%) used CAM, with the most common type being red ginseng and herbal medicine. Patients with a higher income, neuropathy, and self-monitoring of blood glucose (SMBG) were more likely to use CAM. Men, those with a higher education level and income, no cerebrovascular accident (CVA) history, and SMBG showed a relatively higher cost of CAM of total medical cost. The independent predictors for CAM were a higher income, the existence of diabetic neuropathy, no CVA history, and SMBG.

CONCLUSIONS: Use and cost of CAM varied depending on income, accompanying complications and SMBG. To evaluate the total medical costs in DM patients, a comprehensive approach considering not only conventional cost but also CAM is required. CI - Copyright ??2011 Elsevier Ireland Ltd. All rights reserved.
Complementary and alternative medicine; Cost; Diabetes mellitusType 2
MESH
Adult, Aged, Blood Glucose Self-Monitoring, Complementary Therapies/*economics/*methods, Cross-Sectional Studies, Diabetes Mellitus, Type 2/*drug therapy, Female, Humans, Male, Middle Aged, Phytotherapy/methods, Surveys and Questionnaires
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Tthe independent predictors for CAM are a higher income, diabetic neuropathy, no cerebrovascular accident (CVA) history, and self-monitoring of blood glucose (SMBG).
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1016/j.diabres.2011.03.031
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå